457 related articles for article (PubMed ID: 22627631)
21. Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.
Rakha EA; Putti TC; Abd El-Rehim DM; Paish C; Green AR; Powe DG; Lee AH; Robertson JF; Ellis IO
J Pathol; 2006 Mar; 208(4):495-506. PubMed ID: 16429394
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes.
Kim MJ; Ro JY; Ahn SH; Kim HH; Kim SB; Gong G
Hum Pathol; 2006 Sep; 37(9):1217-26. PubMed ID: 16938528
[TBL] [Abstract][Full Text] [Related]
23. Mesothelial markers in high-grade breast carcinoma.
Duhig EE; Kalpakos L; Yang IA; Clarke BE
Histopathology; 2011 Nov; 59(5):957-64. PubMed ID: 22092407
[TBL] [Abstract][Full Text] [Related]
24. Use of immunohistochemical markers can refine prognosis in triple negative breast cancer.
Tischkowitz M; Brunet JS; Bégin LR; Huntsman DG; Cheang MC; Akslen LA; Nielsen TO; Foulkes WD
BMC Cancer; 2007 Jul; 7():134. PubMed ID: 17650314
[TBL] [Abstract][Full Text] [Related]
25. Increased alpha-B-crystallin expression in mammary metaplastic carcinomas.
Chan SK; Lui PC; Tan PH; Yamaguchi R; Moriya T; Yu AM; Shao MM; Hliang T; Wong SI; Tse GM
Histopathology; 2011 Aug; 59(2):247-55. PubMed ID: 21884203
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinomas.
Rodríguez-Pinilla SM; Sarrió D; Honrado E; Hardisson D; Calero F; Benitez J; Palacios J
Clin Cancer Res; 2006 Mar; 12(5):1533-9. PubMed ID: 16533778
[TBL] [Abstract][Full Text] [Related]
27. Metaplastic Carcinoma of the Breast: Analysis of 38 Cases from a Single Institute.
Hasbay B; Bolat FA; Aytaç HÖ; Aslan H; Purbager A
Turk Patoloji Derg; 2020; 36(1):23-30. PubMed ID: 31769499
[TBL] [Abstract][Full Text] [Related]
28. Breast carcinoma in women 35 years and younger: a pathological study.
Fernandopulle SM; Cher-Siangang P; Tan PH
Pathology; 2006 Jun; 38(3):219-22. PubMed ID: 16753742
[TBL] [Abstract][Full Text] [Related]
29. Apocrine ductal carcinoma in situ of the breast: histologic classification and expression of biologic markers.
Leal C; Henrique R; Monteiro P; Lopes C; Bento MJ; De Sousa CP; Lopes P; Olson S; Silva MD; Page DL
Hum Pathol; 2001 May; 32(5):487-93. PubMed ID: 11381366
[TBL] [Abstract][Full Text] [Related]
30. Clinical significance of basal-like subtype in triple-negative breast cancer.
Yamamoto Y; Ibusuki M; Nakano M; Kawasoe T; Hiki R; Iwase H
Breast Cancer; 2009; 16(4):260-7. PubMed ID: 19701681
[TBL] [Abstract][Full Text] [Related]
31. A comprehensive morphological study for basal-like breast carcinomas with comparison to nonbasal-like carcinomas.
Cakir A; Gonul II; Uluoglu O
Diagn Pathol; 2012 Oct; 7():145. PubMed ID: 23082819
[TBL] [Abstract][Full Text] [Related]
32. Basal cytokeratin and epidermal growth factor receptor expression are not predictive of BRCA1 mutation status in women with triple-negative breast cancers.
Collins LC; Martyniak A; Kandel MJ; Stadler ZK; Masciari S; Miron A; Richardson AL; Schnitt SJ; Garber JE
Am J Surg Pathol; 2009 Jul; 33(7):1093-7. PubMed ID: 19390427
[TBL] [Abstract][Full Text] [Related]
33. Breast carcinoma with chondroid differentiation: a clinicopathologic study of 21 triple negative (ER-, PR-, Her2/neu-) cases.
Gwin K; Wheeler DT; Bossuyt V; Tavassoli FA
Int J Surg Pathol; 2010 Feb; 18(1):27-35. PubMed ID: 19282292
[TBL] [Abstract][Full Text] [Related]
34. Bone metastasis is strongly associated with estrogen receptor-positive/progesterone receptor-negative breast carcinomas.
Wei B; Wang J; Bourne P; Yang Q; Hicks D; Bu H; Tang P
Hum Pathol; 2008 Dec; 39(12):1809-15. PubMed ID: 18715613
[TBL] [Abstract][Full Text] [Related]
35. Metaplastic spindle cell breast tumors arising within papillomas, complex sclerosing lesions, and nipple adenomas.
Gobbi H; Simpson JF; Jensen RA; Olson SJ; Page DL
Mod Pathol; 2003 Sep; 16(9):893-901. PubMed ID: 13679453
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ.
Gatalica Z
Pathol Res Pract; 1997; 193(11-12):753-8. PubMed ID: 9521507
[TBL] [Abstract][Full Text] [Related]
37. Paired distribution of molecular subtypes in bilateral breast carcinomas.
Russnes HG; Kuligina ESh; Suspitsin EN; Voskresenskiy DA; Jordanova ES; Cornelisse CJ; Borresen-Dale AL; Imyanitov EN
Cancer Genet; 2011 Feb; 204(2):96-102. PubMed ID: 21504707
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical identification of basal-type cytokeratins in invasive ductal breast carcinoma--relation with grade, stage, estrogen receptor and HER2.
Kusińska R; Potemski P; Jesionek-Kupnicka D; Kordek R
Pol J Pathol; 2005; 56(3):107-10. PubMed ID: 16334976
[TBL] [Abstract][Full Text] [Related]
39. Cytologic features of triple-negative breast carcinoma.
Bonzanini M; Morelli L; Bonandini EM; Leonardi E; Pertile R; Dalla Palma P
Cancer Cytopathol; 2012 Dec; 120(6):401-9. PubMed ID: 22833438
[TBL] [Abstract][Full Text] [Related]
40. Morphologic spectrum of immunohistochemically characterized clear cell carcinoma of the ovary: a study of 155 cases.
DeLair D; Oliva E; Köbel M; Macias A; Gilks CB; Soslow RA
Am J Surg Pathol; 2011 Jan; 35(1):36-44. PubMed ID: 21164285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]